A new study led by the University of Washington found that Muslims and atheists in the United States are more likely than those of Christian faiths to experience religious discrimination. Researchers focused on public schools and tested how principals responded to an individual's expression of religious belief.
When political views are at the extreme ends of the spectrum, they are known as political polarization. Now, communication experts at the University of Missouri have developed a writing exercise as a way to reduce polarization in US politics.
Gratitude interventions in the workplace can help employee well-being and managers can use these efforts to foster more respectful behavior in their teams.
Researchers found that nuanced interactions between teachers and campers at a coding camp for middle school girls as well as among the girls themselves impacted how girls viewed themselves as coders.
New data presented at ESMO 2020 have shown that immunotherapy is beneficial for patients with gastric and oesophageal cancers who currently have poor survival.
Homicides near schools negatively impact on the educational attainment of children, a new study in the Journal of Labor Economics reports.
An international team of researchers has now found that computerised training can support preterm children's academic success. In their randomised controlled study "Fit for School", the researchers compared two learning apps. The project at the University Hospital Essen and at Ruhr-Universität Bochum was funded by Mercator Research Center Ruhr (Mercur) with approximately 300,000 Euros for four years. Results have been published online as unedited manuscript in the journal Pediatric Research on 12 September 2020.
Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free survival (DFS), according to data presented at ESMO 2020. These results give the oncology community a long-awaited answer.
Lugano, Switzerland, 20 September 2020 - Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients with high-risk early hormone receptor positive (HR+) human epidermal growth factor receptor 2 negative (HER2-) breast cancer, according to results from a study at ESMO 2020.
The results of the phase 3 CheckMate 9ER trial have provided a new first-line treatment option for patients with metastatic kidney cancer. The late breaking results are presented at ESMO 2020.